J 2007

The antiapoptotic protein Api5 and its partner, high molecular weight FGF2, are up-regulated in B cell chronic lymphoid leukemia.

KREJČÍ, Pavel, Kateřina PEJCHALOVÁ, B.E. ROSENBLOOM, F.P. ROSENFELT, E.L. TRAN et. al.

Basic information

Original name

The antiapoptotic protein Api5 and its partner, high molecular weight FGF2, are up-regulated in B cell chronic lymphoid leukemia.

Authors

KREJČÍ, Pavel (203 Czech Republic, guarantor, belonging to the institution), Kateřina PEJCHALOVÁ (203 Czech Republic), B.E. ROSENBLOOM (840 United States of America), F.P. ROSENFELT (840 United States of America), E.L. TRAN (840 United States of America), H. LAURELL (840 United States of America) and W.R. WILCOX (840 United States of America)

Edition

Journal of Leukocyte Biology, New York, Society for Leukocyte Biology, 2007, 0741-5400

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30105 Physiology

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 4.128

RIV identification code

RIV/00216224:14310/07:00067362

Organization unit

Faculty of Science

DOI

UT WoS

000251243800001

Keywords in English

FIBROBLAST-GROWTH-FACTOR; api5

Tags

Změněno: 29/4/2014 09:40, prof. Ing. Petr Dvořák, CSc.

Abstract

V originále

The antiapoptotic protein Api5 and its partner, high molecular weight FGF2, were described to be up-regulated in B cell chronic lymphoid leukemia

Links

MSM0021622430, plan (intention)
Name: Funkční a molekulární charakteristiky nádorových a normálních kmenových buněk - identifikace cílů pro nová terapeutika a terapeutické strategie
Investor: Ministry of Education, Youth and Sports of the CR, Functional and molecular characteristics of cancer and normal stem cells - identification of targets for novel therapeutics and therapeutic strategies